Materion
MTRN
$182.47
-10.02%
Materion Corporation is a specialty materials manufacturer producing advanced alloys, beryllium products, precious and non-precious metal systems, inorganic chemicals, vapor deposition targets, and precision optical coatings for semiconductor, aerospace and defense, energy, automotive electronics, consumer electronics, and life sciences end markets. The company occupies a defensible niche as one of the few qualified global suppliers of beryllium-containing and engineered clad/plated materials, giving it specification-locked positions on customer designs rather than commodity pricing power. The current investor narrative centers on a sharp cyclical recovery in semiconductor and aerospace demand — Q3 2026 revenue grew 27.5% year over year to $567.3 million with the semiconductor end market alone contributing roughly $282 million — alongside a margin-recovery story as gross margin climbed from 12.5% in Q4 2025 to 18.3% in Q3 2026. That bullish fundamental narrative has collided with a violent late-2026 share-price drawdown following the November 4 earnings release, leaving investors debating whether the pullback is a buying opportunity in a structurally improved franchise or a warning that peak-cycle expectations are already priced in.…
MTRN
Materion
$182.47
Related headlines
Investment Opinion: Should I buy MTRN Today?
Rating: Hold (with a constructive, accumulation-on-weakness bias). The core thesis is that Materion's fundamental recovery is real — 27.5% YoY revenue growth to $567.3 million and a 580 bps gross-margin climb to 18.3% — but the stock at $203.93 already discounts much of that inflection at roughly 19.3x the $10.545 consensus EPS, leaving limited margin of safety after a -20.3% one-month collapse. The unanimous 3-analyst Buy consensus (KeyBanc Overweight, Freedom Capital Buy, Seaport Global Buy) and Seaport's November 5 upgrade timed to the selloff support the view that downside is becoming more limited than upside, but the absence of published price targets means the consensus cannot be used to anchor a precise expected return.
Supporting evidence is genuinely mixed-to-positive. Revenue has compounded sequentially from $489.8M (Q4 2025) to $549.8M, $613.9M and $567.3M, and gross margin has risen every quarter from 12.5% to 14.4% to 17.0% to 18.3%, lifting Q3 gross profit to $103.7M and EBITDA to $70.5M (12.4% margin). The balance sheet is self-funding: Q3 operating cash flow of $72.2M covered $26.4M capex and $43.9M of debt repayment, trailing FCF is $85.1M (~3.3% yield), and debt-to-equity is a manageable 0.64 with a 3.11 current ratio. Against this, the 34.4x trailing PE, 2.74x price-to-book and 17.8x EV/EBITDA sit at a premium to mid-teens sector norms, while net margin of 4.2% and ROE of 7.9% are thin for that multiple — the market is paying for recovery, not current profitability.
Three risks could invalidate the thesis: (1) margin durability — if Q4 gross margin slips back toward the mid-teens as the Q3 sequential revenue dip (-7.6% from Q2) extends, the ~19x forward multiple loses its earnings support; (2) end-market concentration — semiconductors were roughly $282M of the $567.3M quarter, so a single-cycle rollover hits revenue and operating leverage simultaneously; and (3) thin coverage — 3 analysts with no published targets means one downgrade or estimate cut can move the stock disproportionately, as the November 4 earnings reaction showed. This Hold would upgrade to Buy on a confirmed reclaim of the $227 pre-earnings shelf with gross margin holding above 18%, or on a pullback toward the $177.47 post-earnings low that preserves the margin trajectory; it would downgrade to Sell on a break below $177 that signals a deeper cyclical downturn. Verdict: fairly valued on forward earnings, modestly expensive on trailing metrics — not a bargain, but not a bubble.
Sign up to view all
MTRN 12-Month Price Forecast
Materion presents a genuine fundamental recovery colliding with a violent technical breakdown: revenue is up 27.5% YoY and margins have expanded every quarter for four straight periods, yet the stock has given back roughly a third of its annual advance and sits 36% below its October peak. At ~19.3x forward earnings the valuation is defensible if margins hold above 18%, but the 34.4x trailing PE and 4.2% net margin leave little cushion if the semiconductor cycle rolls over. The unanimous Buy consensus and post-selloff upgrade are encouraging tells, but thin coverage with no published targets means limited price-discovery efficiency and elevated headline risk. I would upgrade to bullish on a confirmed reclaim of $227 with gross margin holding above 18%, and downgrade to bearish on a break below the $177.47 post-earnings low that would signal a deeper cyclical downturn.
Wall Street consensus
Coverage is thin with only 3 analysts, but sentiment is uniformly constructive: the distribution is effectively 3 Buy-equivalent ratings (KeyBanc Overweight, Freedom Capital Markets Buy, Seaport Global Buy) and zero Hold or Sell recommendations, with consensus revenue estimates of $2.70 billion and average EPS of $10.545 for the forward period. No explicit price targets are provided in the data, so implied upside to a consensus target cannot be calculated; however, applying a sector-typical 20x multiple to the $10.545 consensus EPS would imply roughly $211 per share, only marginally above the current $203.93 — suggesting the stock is trading close to fair value on forward earnings even after the drawdown.
The signal strength is mixed: the tight EPS estimate range of $9.74 to $11.13 (about ±7% around the mean) indicates reasonable conviction in the earnings trajectory, and the November 5 upgrade of Seaport Global from Neutral to Buy — timed to the post-earnings selloff — is a meaningful positive tell. KeyBanc has maintained Overweight through eight consecutive actions since January 2026, showing steady institutional support, but the absence of published price targets and the small analyst count mean limited price-discovery efficiency and elevated headline risk. Investors should treat the bullish consensus with caution given the stock's -20% one-month move despite universal Buy ratings — a divergence that suggests either a compelling disconnect or that estimates have yet to be revised lower.
Bulls vs Bears: MTRN Investment Factors
The bull case currently rests on stronger fundamental evidence: 27.5% revenue growth, a 580 bps gross-margin recovery to 18.3%, and a forward multiple near 19x that is far more reasonable than the 34.4x trailing figure. The bear case is primarily technical and valuation-driven — a -20.3% one-month collapse, -44.4% max drawdown, and a premium multiple that assumes margins keep climbing. On balance the fundamental trajectory outweighs the momentum breakdown, but only narrowly, because the stock has already given back roughly a third of its annual advance. The single most important tension is margin durability: if gross margin holds above 18% and volumes stabilize, the ~19x forward multiple looks cheap; if the semiconductor cycle rolls over and margins retreat toward the 12.5% Q4 2025 trough, the trailing premium has no support. Investors should treat the unanimous Buy consensus with caution given the absence of published price targets and the stock's violent post-earnings reaction.
Bullish
- Revenue accelerating at 27.5% YoY: Q3 2026 revenue of $567.3 million grew 27.5% versus $444.8 million in Q3 2025, with semiconductors alone contributing roughly $282 million. The quarterly arc from $489.8M (Q4 2025) to $549.8M, $613.9M and $567.3M shows a genuine cyclical recovery rather than a one-quarter blip.
- Gross margin recovery of 580 bps: Gross margin climbed from 12.5% in Q4 2025 to 14.4% in Q1, 17.0% in Q2 and 18.3% in Q3 2026, lifting gross profit to $103.7 million. Operating leverage is confirmed by EBITDA of $70.5 million (12.4% margin) and operating income of $50.4 million (8.9% margin).
- Forward multiple near 19x consensus EPS: Applying the $10.545 consensus EPS to the $203.93 price implies roughly 19.3x forward earnings, versus a 34.4x trailing PE. The market is paying a reasonable multiple for earnings that are still inflecting, and the 1.44x price-to-sales sits near the low end of its multi-year 3.9x-11.5x range.
- Unanimous Buy coverage, post-selloff upgrade: All 3 covering analysts rate MTRN Buy-equivalent (KeyBanc Overweight, Freedom Capital Buy, Seaport Global Buy) with zero Hold or Sell ratings, and a tight EPS range of $9.74-$11.13 (±7%). Seaport's November 5 upgrade from Neutral to Buy was timed directly to the post-earnings selloff, a meaningful positive tell.
Bearish
- Momentum has decisively broken down: The stock is down 20.3% over one month and 28.0% over three months despite a still-positive 73.8% one-year gain, with relative strength of -18.0 points versus SPY over one month. The -44.4% max drawdown from the October peak near $319 to $203.93 shows trend-following entries have repeatedly been punished.
- Premium valuation on thin current margins: The 34.4x trailing PE is roughly double the sector's mid-teens norm, and 2.74x price-to-book and 17.8x EV/EBITDA sit above typical commodity-materials multiples. Yet net margin is only 4.2% and ROE 7.9% — below what a true premium-multiple franchise should deliver, meaning the market is paying for recovery, not current profitability.
- Sequential revenue already decelerating: Q3 2026 revenue of $567.3 million fell from Q2's $613.9 million, a sequential decline of about 7.6% that warrants monitoring for demand lumpiness. If the semiconductor cycle rolls over, the 34x trailing PE offers little downside protection.
- Thin coverage and no published targets: Only 3 analysts cover the name and no explicit price targets are provided, implying limited price-discovery efficiency and elevated headline risk. The divergence between universal Buy ratings and a -20% one-month move suggests either a compelling disconnect or that estimates have yet to be revised lower.
MTRN Technical Analysis
Materion is in a volatile, range-bound consolidation following a powerful but now-stalled uptrend: the stock is up 73.8% over the trailing year and 58.7% year to date, yet sits only about 64% of the way through its 52-week range after falling from an October peak near $319 to $203.93. That positioning — still deeply profitable for long holders but far off the highs — signals momentum has broken rather than a clean value setup, with the stock effectively retracing roughly a third of its annual advance. The maximum drawdown of -44.4% from peak confirms this is a high-beta, whipsaw-prone name where trend-following entries have repeatedly been punished.
Short-term momentum is decisively negative and diverging sharply from the longer-term trend: the stock is down 20.3% over the past month and 28.0% over three months, versus a still-positive 73.8% one-year gain. Relative strength tells the same story — -18.0 percentage points versus SPY over one month and -25.1 points over three months, against +61.5 points over twelve months — a classic deceleration pattern where the market has aggressively repriced the name lower. The most recent action is telling: a collapse from $227.43 on November 3 to $187.26 on November 4 (the earnings date) and a further low of $177.47 on November 5, followed by a bounce to $203.93, indicating capitulation selling met with dip-buying but no confirmed reversal yet.
Key technical levels are now well defined: support sits at the $177.47 post-earnings low, with secondary support near the $187 area, while resistance has stacked up at $227-$245 (the broken pre-earnings shelf) and then the $312-$319 October highs. A reclaim of $227 would suggest the earnings selloff was overdone; a break below $177 would confirm a deeper downtrend and likely target the mid-$160s. Volatility context matters enormously here — the stock's -44.4% max drawdown and roughly 10% single-day post-earnings moves imply effective volatility well above the market, so position sizing should assume beta-like sensitivity of 1.5x or more even though a formal beta figure is not available in the provided data.
Beta
—
—
Max Drawdown
-44.4%
Largest decline past year
52-Week Range
—
Price range past year
Annual Return
+60.7%
Cumulative gain past year
| Period | MTRN Return | S&P 500 |
|---|---|---|
| 1m | -27.1% | -9.7% |
| 3m | -21.3% | -9.9% |
| 6m | -15.1% | -7.5% |
| 1y | +60.7% | +4.7% |
| ytd | +42.0% | +1.2% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
MTRN Fundamental Analysis
Revenue is on a clear, accelerating recovery trajectory: Q3 2026 revenue of $567.3 million grew 27.5% year over year versus $444.8 million in Q3 2025, and rose sequentially from $549.8 million in Q1 and $613.9 million in Q2 2026 (the Q2 figure reflecting a particularly strong quarter). The multi-quarter arc is unambiguous — quarterly revenue climbed from $489.8 million in Q4 2025 to $549.8M, $613.9M, and $567.3M — with semiconductors the dominant driver at roughly $282.4 million of segment revenue, followed by aerospace and defense at $74.1 million and consumer electronics at $51.2 million. This end-market mix, tilted toward high-growth semiconductor and defense spending, supports the case that the current cycle has legs, though the Q3 sequential dip from Q2 warrants monitoring for demand lumpiness.
Profitability has inflected sharply: Q3 2026 net income was $38.3 million (6.8% net margin) on gross profit of $103.7 million, a 18.3% gross margin that expanded from 17.0% in Q2, 14.4% in Q1, and just 12.5% in Q4 2025. Operating income of $50.4 million (8.9% operating margin) and EBITDA of $70.5 million (12.4% EBITDA margin) confirm the operating leverage is real, and the swing from a -$48.9 million net loss in Q4 2024 to consistent profitability through 2026 shows the trough is behind the company. Gross margins in the high-teens are reasonable for a specialty materials processor but below the 20-22% levels seen in 2022-2023, leaving room for further recovery if volumes hold.
Balance-sheet and cash-flow health is solid but not fortress-like: debt-to-equity of 0.64, a current ratio of 3.11, and trailing free cash flow of $85.1 million against a $2.58 billion market cap imply an FCF yield of roughly 3.3%, while ROE of 7.9% remains modest for the valuation. Q3 operating cash flow of $72.2 million funded $26.4 million of capex and $43.9 million of debt repayment, showing the business now self-funds growth and deleveraging; however, Q1 2026 free cash flow was -$19.6 million due to working-capital build, highlighting the cyclical cash drag from inventory and receivables. Interest coverage of roughly 7.6x and a dividend payout ratio of about 15% leave adequate cushion, but the 0.64 leverage and thin 4.2% net margin mean the equity is sensitive to any volume disappointment.
Quarterly Revenue
$567290000.0B
2026-10
Revenue YoY Growth
+27.5%
YoY Comparison
Gross Margin
18.3%
Latest Quarter
Free Cash Flow
$85117000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is MTRN Overvalued?
Because Materion is profitable (Q3 2026 net income of $38.3 million), the PE ratio is the appropriate primary metric: the trailing PE stands at 34.4x while the forward PE of roughly 0.03x in the provided data is clearly a data artifact (it appears to be a PEG-style or mis-scaled field) and should be disregarded; using the analyst consensus EPS of $10.545 against the $203.93 price implies a far more reasonable forward multiple near 19.3x. That gap between 34.4x trailing and ~19x forward implies the market expects earnings to roughly double, consistent with the margin-recovery trajectory from 12.5% to 18.3% gross margin over four quarters.
Against the Basic Materials/industrial materials peer set, the stock screens as a premium name: a 2.74x price-to-book, 1.44x price-to-sales, and 17.8x EV/EBITDA sit above typical commodity-materials multiples, while the 34.4x trailing PE is well above the sector's mid-teens norm — a premium of roughly 100% or more. That premium is partly justified by the specialty, specification-locked nature of the business and its semiconductor/aerospace exposure, but the 4.2% net margin and 7.9% ROE are below what a true premium-multiple franchise should deliver, suggesting the market is paying for the recovery rather than current profitability.
Historically, Materion's own PE has ranged from roughly 15x-16x in 2022 to over 90x during loss-distorted periods, with the current 34.4x sitting in the upper-middle of that band but far below the 42.4x and 35.7x readings in Q3 and Q2 2026 — meaning the multiple has actually compressed as earnings caught up. The price-to-sales ratio of 1.44x is near the low end of its multi-year 3.9x-11.5x range, a stark divergence that reflects the market's skepticism about margin durability despite the revenue base nearly doubling; if margins hold, the stock looks inexpensive on sales, but if the cycle rolls over, the 34x trailing PE offers little downside protection.
PE
34.4x
Latest Quarter
vs. Historical
Mid-Range
5-Year PE Range 16x~51x
vs. Industry Avg
25.2x
Industry PE ~25.2x*
EV/EBITDA
17.8x
Enterprise Value Multiple
Investment Risk Disclosure
Financial and operational risks center on margin durability and cyclical cash drag. Gross margin recovered from 12.5% in Q4 2025 to 18.3% in Q3 2026, but that is still below the 20-22% levels of 2022-2023, and the 4.2% net margin and 7.9% ROE are thin for a 34.4x trailing PE. Q1 2026 free cash flow was -$19.6 million on working-capital build, showing that inventory and receivables can absorb cash precisely when volumes surge. Debt-to-equity of 0.64 with roughly $6.6 million of quarterly interest expense and about 7.6x coverage is manageable, but the equity is highly sensitive to any volume disappointment given the thin margin cushion. Revenue concentration adds risk: semiconductors contributed roughly $282 million of the $567.3 million quarter, so a single end-market slowdown would hit both revenue and the operating leverage story simultaneously.
Market and competitive risks are dominated by valuation compression. At 34.4x trailing earnings, 2.74x book and 17.8x EV/EBITDA, MTRN trades at roughly a 100% premium to the sector's mid-teens PE norm, a premium justified only if margins keep recovering. The stock's -44.4% max drawdown and roughly 10% single-day post-earnings moves imply effective volatility well above the market, with beta-like sensitivity of 1.5x or more. Coverage is thin at 3 analysts with no published price targets, so a single downgrade or estimate cut can move the shares disproportionately — as the November 4 earnings reaction demonstrated. The recent institutional-flow news around comparable specialty-material names such as Rogers Corporation highlights that funds are actively rotating within the sector based on margin-recovery conviction, which cuts both ways for MTRN.
In a worst-case scenario, semiconductor orders normalize faster than expected, Q4 gross margin slips back toward the mid-teens, and consensus EPS of $10.545 gets cut toward the $9.74 low end or below. That would compress the forward multiple from ~19x toward the sector's mid-teens while earnings fall, a double hit. The realistic downside anchors to the November 5 post-earnings low of $177.47, roughly -13% from the current $203.93, and a break below that level would likely target the mid-$160s, about -20%. In a deeper cyclical reversal, a retest of the -44.4% max-drawdown profile from the $319 peak would imply losses of 30% or more from current levels. Position sizing should assume this downside is plausible, not remote.
FAQ
The most severe risk is margin durability, because the entire forward valuation rests on gross margin holding near 18.3% after a four-quarter climb from 12.5%; a retreat toward the mid-teens as the Q3 sequential revenue decline (-7.6% from $613.9M to $567.3M) extends would undercut the ~19x forward multiple and likely cut consensus EPS toward the $9.74 low end. Second is end-market concentration: semiconductors contributed roughly $282 million of the $567.3 million quarter, so a single-cycle normalization would hit revenue and operating leverage simultaneously. Third is valuation and momentum risk — 34.4x trailing PE, 2.74x book and a -44.4% max drawdown from the $319 October peak mean the stock has repeatedly punished trend-following entries, and relative strength is -18.0 points versus SPY over one month. Fourth is thin coverage and cyclical cash drag: only 3 analysts with no published price targets means one downgrade can move the stock disproportionately, while Q1 2026 free cash flow of -$19.6 million on working-capital build shows cash can evaporate precisely when volumes surge, against 0.64 debt-to-equity and a thin 4.2% net margin.
The 12-month forecast splits into three scenarios weighted toward consolidation. The base case (50% probability, $195-$225) assumes revenue stabilizes near the $2.70 billion consensus, gross margin holds in the high-teens, and EPS lands near $10.545, supporting a 19-21x forward multiple — essentially flat to modestly higher from $203.93. The bull case (25%, $255-$285) requires gross margin pushing from 18.3% toward the 20-22% levels of 2022-2023 and EPS migrating toward the $11.13 high end, which at a 23-26x multiple would retest the broken $245-$285 resistance shelf. The bear case (25%, $160-$180) assumes faster semiconductor normalization cuts EPS toward $9.74 or below while the multiple compresses toward the sector's mid-teens, retesting the $177.47 post-earnings low and then the mid-$160s. The base case is most likely because the tight ±7% EPS estimate range signals reasonable conviction in the earnings trajectory, but the key assumption — high-teens gross margin durability — is exactly what the market is currently questioning.
The answer depends heavily on which multiple you use, and that gap is the heart of the debate. On trailing figures MTRN looks expensive: 34.4x PE, 2.74x price-to-book and 17.8x EV/EBITDA all sit well above the mid-teens PE norm for industrial materials, and a 4.2% net margin with 7.9% ROE is thin for that premium. On forward earnings it looks closer to fair: $203.93 divided by the $10.545 consensus EPS implies roughly 19.3x, only marginally above the ~$211 a sector-typical 20x multiple would justify, and the 1.44x price-to-sales sits near the low end of its multi-year 3.9x-11.5x range. The market is therefore paying for an earnings recovery rather than current profitability — it expects margins to hold in the high-teens and EPS to roughly double from trailing levels. That is a fair price if the recovery is structural, but the trailing premium offers little protection if the semiconductor cycle rolls over, so the stock is best described as fairly valued on forward earnings and modestly expensive on trailing metrics.
From a risk/reward standpoint MTRN is a reasonable but not compelling buy at $203.93. The bull case is anchored in 27.5% YoY revenue growth to $567.3 million and a 580 bps gross-margin recovery to 18.3%, which at roughly 19.3x the $10.545 consensus EPS leaves room for multiple expansion if margins hold; the unanimous 3-analyst Buy consensus and Seaport's November 5 upgrade timed to the selloff reinforce that downside is becoming more limited. The offset is that no published price targets exist to quantify upside, and the stock has already fallen 20.3% in a month and 28.0% in three months despite universal Buy ratings — a divergence that could mean either a disconnect or unrevised estimates. The biggest downside risk is a semiconductor rollover that pushes gross margin back toward the mid-teens and EPS toward the $9.74 low end, a scenario that targets $160-$180, or -12% to -21%. It is a good buy primarily for investors with a 12-24 month horizon who size positions for a -44.4% max-drawdown profile and are willing to accumulate on weakness toward $177-$187 rather than chase strength.
MTRN is better suited to a medium-to-long-term holding period of at least 12-24 months than to short-term trading. The business is in a genuine cyclical recovery — revenue up 27.5% YoY and gross margin up 580 bps over four quarters — but earnings visibility is limited by semiconductor cyclicality, thin 3-analyst coverage with no published targets, and quarterly results that have produced roughly 10% single-day moves. Short-term traders face a -44.4% max drawdown, -20.3% one-month and -28.0% three-month momentum, and relative strength of -18.0 points versus SPY, an environment where trend-following entries have repeatedly been punished. Long-term holders are compensated modestly along the way: the dividend yield is only 0.45% with a 15.4% payout ratio, so total return depends almost entirely on earnings growth and multiple re-rating rather than income. A reasonable approach is a staged accumulation over 6-12 months, adding toward the $177-$187 support zone and trimming into the $245-$285 resistance shelf, with a minimum 12-month horizon to let the margin-recovery thesis play out through at least two more earnings cycles.

